From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
September 3, 2020
Philadelphia, PA, September 3, 2019 – IntegriChain, a leading data and managed services company helping Life Sciences manufacturers deliver access to innovative therapies that significantly improve patient lives, today announced that the company’s subject matter experts will present at the upcoming Medicaid Drug Rebate Program (MDRP) Conference. The virtual conference runs September 14-18.
IntegriChain speakers include:
Jennifer Sharpe, Segment Lead, Gross-to-Net, will present “GTN Budgeting for Medicaid Accruals and Utilization” for an on-demand session available throughout the conference.
Tom Evegan, Vice President, Life Sciences, will participate in an Executive Counsel Roundtable on Friday, September 18, at 11 am ET.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 240 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India.For more information, visit integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
